Prilosec Bioequivalence Study in Healthy Volunteers
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This is An Open-label, Randomized, Single-center, 4-way Crossover, Single dose Bioequivalence
Study Comparing Omeprazole 20 and 40-mg Aqueous solvent Based Capsules Manufactured by
AstraZeneca with Omeprazole 20 and 40-mg Organic-solvent Based Capsules Manufactured by Merck